These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 27934063)
1. Uncovering the Binding and Specificity of β-Wrapins for Amyloid-β and α-Synuclein. Orr AA; Wördehoff MM; Hoyer W; Tamamis P J Phys Chem B; 2016 Dec; 120(50):12781-12794. PubMed ID: 27934063 [TBL] [Abstract][Full Text] [Related]
2. Sequestration of a β-hairpin for control of α-synuclein aggregation. Mirecka EA; Shaykhalishahi H; Gauhar A; Akgül Ş; Lecher J; Willbold D; Stoldt M; Hoyer W Angew Chem Int Ed Engl; 2014 Apr; 53(16):4227-30. PubMed ID: 24623599 [TBL] [Abstract][Full Text] [Related]
3. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases. Kreutzer AG; Nowick JS Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987 [TBL] [Abstract][Full Text] [Related]
4. Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro. Köppen J; Schulze A; Machner L; Wermann M; Eichentopf R; Guthardt M; Hähnel A; Klehm J; Kriegeskorte MC; Hartlage-Rübsamen M; Morawski M; von Hörsten S; Demuth HU; Roßner S; Schilling S Molecules; 2020 Jan; 25(3):. PubMed ID: 32013170 [TBL] [Abstract][Full Text] [Related]
5. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases. Atsmon-Raz Y; Miller Y ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553 [TBL] [Abstract][Full Text] [Related]
6. Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of β-Amyloid and α-Synuclein Aggregates. Watanabe H; Ono M; Ariyoshi T; Katayanagi R; Saji H ACS Chem Neurosci; 2017 Aug; 8(8):1656-1662. PubMed ID: 28467708 [TBL] [Abstract][Full Text] [Related]
7. Complexation of NAC-Derived Peptide Ligands with the C-Terminus of α-Synuclein Accelerates Its Aggregation. Jha NN; Ranganathan S; Kumar R; Mehra S; Panigrahi R; Navalkar A; Ghosh D; Kumar A; Padinhateeri R; Maji SK Biochemistry; 2018 Feb; 57(5):791-804. PubMed ID: 29286644 [TBL] [Abstract][Full Text] [Related]
8. A simple algorithm locates beta-strands in the amyloid fibril core of alpha-synuclein, Abeta, and tau using the amino acid sequence alone. Zibaee S; Makin OS; Goedert M; Serpell LC Protein Sci; 2007 May; 16(5):906-18. PubMed ID: 17456743 [TBL] [Abstract][Full Text] [Related]
9. Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors. Jha NN; Kumar R; Panigrahi R; Navalkar A; Ghosh D; Sahay S; Mondal M; Kumar A; Maji SK ACS Chem Neurosci; 2017 Dec; 8(12):2722-2733. PubMed ID: 28872299 [TBL] [Abstract][Full Text] [Related]
10. Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study. Doytchinova I; Atanasova M; Salamanova E; Ivanov S; Dimitrov I Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32942739 [TBL] [Abstract][Full Text] [Related]
11. Impact of subunit linkages in an engineered homodimeric binding protein to α-synuclein. Gauhar A; Shaykhalishahi H; Gremer L; Mirecka EA; Hoyer W Protein Eng Des Sel; 2014 Dec; 27(12):473-9. PubMed ID: 25332193 [TBL] [Abstract][Full Text] [Related]
12. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders. El-Agnaf OM; Paleologou KE; Greer B; Abogrein AM; King JE; Salem SA; Fullwood NJ; Benson FE; Hewitt R; Ford KJ; Martin FL; Harriott P; Cookson MR; Allsop D FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of amyloid-β plaque formation by α-synuclein. Bachhuber T; Katzmarski N; McCarter JF; Loreth D; Tahirovic S; Kamp F; Abou-Ajram C; Nuscher B; Serrano-Pozo A; Müller A; Prinz M; Steiner H; Hyman BT; Haass C; Meyer-Luehmann M Nat Med; 2015 Jul; 21(7):802-7. PubMed ID: 26099047 [TBL] [Abstract][Full Text] [Related]
14. Structure-based design of conformation- and sequence-specific antibodies against amyloid β. Perchiacca JM; Ladiwala AR; Bhattacharya M; Tessier PM Proc Natl Acad Sci U S A; 2012 Jan; 109(1):84-9. PubMed ID: 22171009 [TBL] [Abstract][Full Text] [Related]
15. Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation. Lu JH; Ardah MT; Durairajan SS; Liu LF; Xie LX; Fong WF; Hasan MY; Huang JD; El-Agnaf OM; Li M Chembiochem; 2011 Mar; 12(4):615-24. PubMed ID: 21271629 [TBL] [Abstract][Full Text] [Related]
16. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology. Coskuner-Weber O; Uversky VN Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151 [TBL] [Abstract][Full Text] [Related]
17. Molecular Dynamics Study to Investigate the Dimeric Structure of the Full-Length α-Synuclein in Aqueous Solution. Zhang T; Tian Y; Li Z; Liu S; Hu X; Yang Z; Ling X; Liu S; Zhang J J Chem Inf Model; 2017 Sep; 57(9):2281-2293. PubMed ID: 28796507 [TBL] [Abstract][Full Text] [Related]
18. The Amyloid Fibril-Forming β-Sheet Regions of Amyloid β and α-Synuclein Preferentially Interact with the Molecular Chaperone 14-3-3ζ. Williams DM; Thorn DC; Dobson CM; Meehan S; Jackson SE; Woodcock JM; Carver JA Molecules; 2021 Oct; 26(20):. PubMed ID: 34684701 [TBL] [Abstract][Full Text] [Related]
19. Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 39 in membrane insertion. Fantini J; Yahi N J Mol Biol; 2011 May; 408(4):654-69. PubMed ID: 21396938 [TBL] [Abstract][Full Text] [Related]
20. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study. Sun Y; Qian Z; Wei G Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]